Literature DB >> 26578702

Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".

Amanda Fortes Francisco1, Michael D Lewis1, Shiromani Jayawardhana1, Martin C Taylor1, Eric Chatelain2, John M Kelly3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26578702      PMCID： PMC4649144          DOI： 10.1128/AAC.02022-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  4 in total

1.  Antitrypanosomal Treatment with Benznidazole Is Superior to Posaconazole Regimens in Mouse Models of Chagas Disease.

Authors:  Shilpi Khare; Xianzhong Liu; Monique Stinson; Ianne Rivera; Todd Groessl; Tove Tuntland; Vince Yeh; Ben Wen; Valentina Molteni; Richard Glynne; Frantisek Supek
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

2.  Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

Authors:  Israel Molina; Jordi Gómez i Prat; Fernando Salvador; Begoña Treviño; Elena Sulleiro; Núria Serre; Diana Pou; Sílvia Roure; Juan Cabezos; Lluís Valerio; Albert Blanco-Grau; Adrián Sánchez-Montalvá; Xavier Vidal; Albert Pahissa
Journal:  N Engl J Med       Date:  2014-05-15       Impact factor: 91.245

3.  Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.

Authors:  Amanda Fortes Francisco; Michael D Lewis; Shiromani Jayawardhana; Martin C Taylor; Eric Chatelain; John M Kelly
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

4.  Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development.

Authors:  Carolina B Moraes; Miriam A Giardini; Hwayoung Kim; Caio H Franco; Adalberto M Araujo-Junior; Sergio Schenkman; Eric Chatelain; Lucio H Freitas-Junior
Journal:  Sci Rep       Date:  2014-04-16       Impact factor: 4.379
  4 in total
  1 in total

Review 1.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.